Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
33,696,160
-
Share change
-
+1,410,809
-
Total reported value
-
$501,006,013
-
Price per share
-
$14.87
-
Number of holders
-
128
-
Value change
-
+$17,095,503
-
Number of buys
-
75
-
Number of sells
-
51
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2017
As of 31 Dec 2017 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,696,160 shares of stock of the company.
Largest 10 holders included BlackRock Inc., EAGLE ASSET MANAGEMENT INC, Novo Holdings A/S, CARILLON TOWER ADVISERS, INC., PERCEPTIVE ADVISORS LLC, Vanguard Group Inc, Nantahala Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and MILLENNIUM MANAGEMENT LLC.
This table shows 128 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.